Amino acid replacement: ?129term.
C18135113T
Q129term | ari-1-PA; Q129term | ari-1-PB; Q129term | ari-1-PC; Q129term | ari-1-PD; Q129term | ari-1-PE; Q129term | ari-1-PF
?129term
Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.
Adult male survivors are seen at a low frequency (less than 10%). ari-11199/ari-13747 animals are viable. The paternal introduction of ari-13747 results in 30% viability, while viability drops to 3% if ari-13747 is introduced maternally. ari-11199/ari-13747 females have an abnormally small number of ovarioles and arrested cyst development is occasionally seen. ari-11199/ari-13747 escapers show severe structural defects in the tergal depressor of the trochanter (TDT) muscle. The DVMII muscles appear reduced in size but with a relatively normal structure. The negative sustained component of the electroretinogram of mutant escapers is reduced to 1/3 of controls. The amplitude of the on and off transients is reduced by approximately 30%. Females carrying homozygous germline clones can produce offspring, indicating that the ari-11199 mutation does not prevent oogenesis.
ari-11199, wupA8384 has partially lethal phenotype
Heterozygotes with wupA8384 are poorly viable.
Induced on: a f5 osunspecified chromosome.
Mutation in the haplo-lethal (HL) region of the Sh complex.
Mutation within the haplo-lethal (HL) region of the Sh complex.